Evidence-based·Last reviewed June 1, 2026·How we grade evidence

Lysozyme

Enzyme

A natural antimicrobial enzyme abundant in human secretions, breast milk, and egg white. Used commercially as a food preservative (cheese) and sold OTC in Italy as a throat lozenge for pharyngitis. Direct RCT evidence in adults for sore throat or respiratory infections is limited and dated; no robust evidence for systemic oral supplementation for general 'immune support.' Carries a real allergen concern for people with egg allergy.

Quick decision guide

May help most

Adult use of lozenge-form lysozyme for sore throat in regions where it's marketed (Italy, parts of Asia) as an adjunct to symptomatic care. Industrial food-preservation use is the most established application.

Common dosing range

Throat lozenge formulations: 20 mg lysozyme per lozenge, 4–6 lozenges/day (regulatory products in Italy). Capsule supplements: highly variable (100–500 mg); no established evidence-based oral dose.

When to expect effects

Lozenges: local action while dissolving in the mouth. Systemic oral supplementation: most lysozyme is digested in the stomach, so any systemic effect is unproven.

Watch out for

Egg allergy — lysozyme is one of the major egg-white allergens (Gal d 4). Anyone with egg allergy must avoid lysozyme supplements, lozenges, AND lysozyme-containing cheeses or wines.

Evidence snapshot

Food preservative (cheese, sausage)Strong
Throat lozenge (pharyngitis adjunct)Emerging
Oral supplement for systemic immunityLow
Bovine-lysozyme infant formula (Latin America/Asia)Emerging

What is it

Lysozyme is an enzyme that hydrolyzes peptidoglycan in bacterial cell walls. It is abundant in egg white, tears, saliva, and breast milk. Supplemental lysozyme is typically derived from egg white and used for upper respiratory and immune support.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You're in a region where lysozyme lozenges are sold OTC (Italy, parts of Asia) and want a local-acting adjunct for a sore throat
You're using it knowingly as a food preservative in artisanal cheesemaking
You're researching lactation/infant feeding and interested in the role of milk lysozyme in infant gut defence
You don't have egg allergy and you've checked that the product is clearly labelled as egg-derived

Probably skip if

You have egg allergy — lysozyme is itself a major egg allergen (Gal d 4); avoid the supplement AND lysozyme-containing cheeses and wines
You're hoping a capsule will give you systemic antibacterial effect — most lysozyme is digested in the stomach; no robust RCT evidence supports systemic oral use
You're using it to treat a serious infection without medical care — it's an adjunct at best, not antibiotic therapy
You're pregnant or breastfeeding and considering high-dose supplementation — no clinical safety data at supplement doses
You're hoping it will prevent or treat COVID-19, flu, or other viral infections — no clinical-trial evidence to support that

Evidence at a glance

Local antimicrobial action in throat lozenges

Limited Evidence
Effect
Symptomatic relief comparable to or modestly better than placebo lozenges in older Italian trials; no large modern RCTs
Best fit
Adults in regions where the lozenge is regulated OTC, using it as an adjunct to standard sore-throat care
Time
Minutes (local action while dissolving)

Bovine lysozyme in infant formula (low-resource diarrheal disease)

Limited Evidence
Effect
Lower incidence of bacterial gut colonization in pig models; small human trials suggest reduced diarrhoea duration. Public-health-scale benefit not yet established.
Best fit
Formula-fed infants in low-resource settings with high diarrheal-disease burden — research-stage intervention
Time
Cumulative protective effect over weeks of feeding

Oral supplement for general 'immune support' or systemic antibacterial effect

Mixed Evidence
Effect
No clinical-trial-grade evidence for systemic benefit from oral capsules
Best fit
Time
Not established

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Local antimicrobial action in throat lozenges

Supplement benefit
Limited Evidence

Lysozyme has been sold in Italy as an OTC throat lozenge for pharyngitis since the late 1950s, based on its in vitro lytic activity against Gram-positive bacteria (which dominate pharyngeal flora). Modern RCT evidence is sparse and dated; most trials are small, Italian-language, and predate modern methodological standards. The mechanism is plausible and the safety profile (at lozenge doses, for non-egg-allergic users) is goodbut the evidence base is best described as 'long traditional use with limited modern controlled-trial confirmation.'

Effect size
Symptomatic relief comparable to or modestly better than placebo lozenges in older Italian trials; no large modern RCTs
Time to effect
Minutes (local action while dissolving)
Best fit
Adults in regions where the lozenge is regulated OTC, using it as an adjunct to standard sore-throat care
Less likely
Anyone with a bacterial throat infection requiring antibiotics — lysozyme lozenges are not a substitute for antibiotic therapy

Bottom line: Reasonable local adjunct for sore throat in regions where it's regulated OTC; not a substitute for medical care of bacterial throat infections.

Bovine lysozyme in infant formula (low-resource diarrheal disease)

Mechanism only
Limited Evidence

Breast milk lysozyme is associated with reduced diarrheal-disease incidence in breastfed vs formula-fed infants. Researchers (notably at UC Davis and Latin American collaborators) have developed transgenic-cow-derived lysozyme-enriched infant formulas; early controlled trials in pigs and humans suggest reduced infectious diarrhoea in formula-fed infants. This is a public-health research application, not a consumer supplement category.

Effect size
Lower incidence of bacterial gut colonization in pig models; small human trials suggest reduced diarrhoea duration. Public-health-scale benefit not yet established.
Time to effect
Cumulative protective effect over weeks of feeding
Best fit
Formula-fed infants in low-resource settings with high diarrheal-disease burden — research-stage intervention
Less likely
General consumer supplement use — this isn't the same as a retail capsule product

Bottom line: Promising research direction for infant nutrition in specific contexts; not a consumer-supplement use case.

Oral supplement for general 'immune support' or systemic antibacterial effect

Mechanism only
Mixed Evidence

Lysozyme is a protein and is rapidly digested in the stomach. Capsule supplements that promise 'natural antibiotic' or 'immune boost' effects from oral lysozyme have essentially no clinical-trial support for systemic actionwhat reaches the small intestine, let alone the bloodstream, is minimal. Local mouth/throat action via lozenges is mechanistically sensible; systemic oral capsule action is not.

Effect size
No clinical-trial-grade evidence for systemic benefit from oral capsules
Time to effect
Not established
Best fit
Less likely
Anyone hoping a capsule will deliver systemic antibacterial effect

Bottom line: If you're going to use lysozyme, use a lozenge for local effect — capsules don't have evidence for systemic action.

How it works

Lysozyme breaks down the cell walls of gram-positive bacteria, contributing to antimicrobial defense in mucosal secretions. Some clinical research, mainly in Italy, has explored oral and lozenge lysozyme for sore throat, dental caries, and viral respiratory illness. Effects appear modest and largely topical (in the mouth/throat).

How to take it

1. Typical dose
LOZENGE (Italy / parts of Asia): • 20 mg lysozyme per lozenge • 4–6 lozenges/day, dissolved slowly in the mouth • Up to 1 week per episode of sore throat CAPSULE SUPPLEMENT (US / EU online): • 100–500 mg/day — manufacturer-recommended; no evidence-based optimum dose • Limited efficacy evidence for systemic effect; lozenge-form is more rational
2. Higher studied dose
Lozenge doses up to ~120 mg/day (6 × 20 mg) are within the marketed range; capsule doses up to 1 g/day have been used in trial-grade work for cancer chemotherapy adjunct, but those are research settings, not consumer use.
3. Timing
Lozenges: as needed for symptomatic sore throat, spaced 2–3 hours apart. Capsules: with or without food, but oral lysozyme is rapidly digested either way.
4. With food
Either way (limited effect of food on lozenge action).
5. Split dosing
Lozenges: spread doses across the day for sustained local action. Capsules: split if you prefer; no clear evidence-based advantage.
6. How long to try
Lozenges: short courses (5–7 days per sore throat episode). Capsules: no established duration; reassess if you don't feel a clear benefit after 2 weeks.

What to track

Sore throat symptom scores (pain, swallowing, throat redness)
Any allergic reaction (lip/tongue swelling, hives, wheezing) — particularly important if you have egg allergy
Whether you actually need antibiotic care (persistent fever, exudates, severe pain) — see a clinician
GI tolerance (lysozyme is generally well-tolerated at lozenge doses)

Bottom line: Lozenge form for short-term sore-throat use is the most rational application. Capsules for systemic effect are not well-supported. Avoid entirely if you have egg allergy.

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Throat lozenge (egg lysozyme)

Most rational

20 mg lysozyme per lozenge in marketed Italian formulations (e.g., Lisozima, Hyalugel). Local action while dissolving in the mouth and throat. Generally well-tolerated; not a substitute for antibiotics if you have bacterial pharyngitis.

Local action only — minimal systemic absorption.

Capsule supplement (egg lysozyme)

Weak rationale

100500 mg per capsule; sold as 'natural antibiotic' or 'immune support.' Oral lysozyme is rapidly digested in the stomach, so systemic effect is unproven. The lozenge form has a clearer mechanism.

Largely digested in the stomach; systemic effect not established.

Food-additive lysozyme (E1105) in cheese and wine

Industrial use

Added to hard and semi-hard cheeses (Grana Padano, Provolone, others) to prevent late-blowing defects from Clostridium spp. Also used in some wines. Foods containing lysozyme must declare it as a derivative of eggimportant for people with egg allergy.

Food preservative use; egg-allergen risk requires labelling.

Bovine lysozyme in research-stage infant formula

Research

Transgenic-cow-derived lysozyme-enriched formula being studied as a public-health intervention in low-resource settings for reducing infant diarrhoea. Not a consumer-supplement category.

Research-stage; not commercially available as supplement.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

rare GI upset at high oral doseslocal mucosal irritation from lozenges (uncommon)altered taste perception while a lozenge is dissolving

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Dietary lysozyme exposure (breast milk, lysozyme-preserved cheese) is part of normal life and considered safe in pregnancy if you don't have egg allergy. No safety data for high-dose supplements during pregnancy or breastfeeding — avoid pharmacological doses without obstetric guidance.

Bottom line: Generally safe at lozenge and food-additive doses for non-egg-allergic adults. Absolutely contraindicated in egg allergy. Pediatric and pregnancy supplement use are not well-supported.

Interactions

egg-allergen-containing foods (cheeses, wines with lysozyme preservative)Major

For egg-allergic individuals — lysozyme retains its allergenicity in foods and can cause systemic allergic reactions including anaphylaxis. Read labels carefully; lysozyme must be declared as a derivative of egg.

antibiotics and antifungalsMinor

Lysozyme has its own narrow antimicrobial activity; theoretically additive but no clinically meaningful interactions documented. Use as adjunct to, not substitute for, prescribed antibiotics when those are needed.

Food sources

Egg white, raw — 1 large egg (~33 g)

Amount
~3–4 mg lysozyme (~6–8% of egg-white protein when isolated)
%DV

Human breast milk

Amount
~400 mg/L lysozyme (rises in later lactation)
%DV

Saliva, tears, nasal mucus

Amount
Endogenous human source; not a dietary supply
%DV

Hard cheeses with E1105 lysozyme preservative (Grana Padano, Provolone)

Amount
Trace residual lysozyme; egg-allergen risk for sensitive individuals
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Egg-derived source clearly stated on the label (FDA and EFSA require this disclosure)
Standardized enzyme activity (units of muramidase activity), not just mg of protein
Lozenge form for local antimicrobial action; capsules have weaker rationale for systemic effect
Third-party tested for purity and enzyme activity (the assay is straightforward and reputable manufacturers will publish it)
Regulatory status in your jurisdiction — lozenges are OTC in Italy, supplements in the US

Be skeptical of

'Natural antibiotic' / 'replaces antibiotics' — lysozyme is a narrow-spectrum local agent, not antibiotic therapy
'Boosts immunity' / 'systemic immune support' from capsules — most oral lysozyme is digested in the stomach
'Antiviral against COVID/flu' marketing — no clinical-trial evidence supports this
'Cures cancer' or 'lysozyme cancer treatment' — older research was preclinical; no clinical efficacy established
Lysozyme products without egg-allergen labelling — both FDA and EFSA require disclosure

Frequently asked questions

Can lysozyme treat infections?

Not in any meaningful systemic sense. Some local benefit for sore throat is plausible from lozenge forms.

Is it safe for kids?

Pediatric lozenges exist in some countries; egg allergy must be ruled out.

References by claim

Safety

EFSA Panel on Food Additives, 2007EFSA Journal (2007) link

FDA GRAS Notice GRN 64 — LysozymeUS Food and Drug Administration (2000) link

Local antimicrobial action in throat lozenges

Sava, 1996PubMed — EXS (Experientia Supplementum) (1996) link

Bovine lysozyme in infant formula (low-resource diarrheal disease)

Lönnerdal, 2003PubMed — American Journal of Clinical Nutrition (2003) link

Other references

JECFA / FAO–WHO Specifications — LysozymeJoint FAO/WHO Expert Committee on Food Additives (2018) link

Lysozyme on NIH DSLDNIH Dietary Supplement Label Database link

Track Lysozyme with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed Jun 1, 2026·Evidence current as of Jun 1, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.